Pura Vida Investments’s AtriCure ATRC Stock Holding History

Pura Vida Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-49,800	Closed	-$3.26M	–	224
2021 Q1	$3.26M	Buy	+49,800	New	+$3.07M	0.09%	140
2020 Q4	–	Sell	-75,000	Closed	-$2.99M	–	181
2020 Q3	$2.99M	Buy	+75,000	New	+$3.18M	0.15%	107
2020 Q2	–	Sell	-565,000	Closed	-$19M	–	124
2020 Q1	$19M	Buy	+565,000	New	+$20.3M	2.25%	12

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pura Vida Investments's ATRC Position: Q2 2023 in Review

Pura Vida Investments sold out of AtriCure (ATRC) in Q2 2023, closing a stake of 56,219 shares — an estimated $2.33M sold.

Pura Vida Investments first reported a position in ATRC in Q4 2015 and held it in 17 quarters. The position peaked at $44.9M in Q2 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q2 2023.

Pura Vida Investments reported no remaining AtriCure position as of Q2 2023 after selling out during the quarter.
Pura Vida Investments sold 56,219 AtriCure shares in Q2 2023, an estimated $2.33M.
Pura Vida Investments first reported a position in AtriCure in Q4 2015 and held it in 17 quarters.
Pura Vida Investments's AtriCure position peaked at $44.9M in Q2 2021.
223 funds tracked by Wall St. Rank held AtriCure as of Q2 2023.

Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.